| Phillip Carl Hoopes, Jr, MD | |
|
11820 S. State St, Ste. 200, Draper, UT 84020-7160 | |
| (801) 568-0200 | |
| (801) 563-0200 |
| Full Name | Phillip Carl Hoopes, Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 11820 S. State St, Draper, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992794846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 57266371205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hoopes Vision Correction Center Pc | 7618874231 | 9 |
News Archive
Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.
Methods currently employed to determine the severity of a heart failure are very limited. Researchers at Eindhoven University of Technology and the Catharina Hospital in Eindhoven have therefore developed a method that is very quick, non-invasive, cost-effective and can be performed at the hospital bedside.
One of the basic tenets of targeted nanoparticle drug delivery is putting multiple targeting molecules on a nanoparticle surface will improve the ability of nanoparticles to stick to their targeted cell and deliver their drug cargos to the appropriate diseased cell.
A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.
› Verified 5 days ago
| Entity Name | Hoopes Vision Correction Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982759122 PECOS PAC ID: 7618874231 Enrollment ID: O20031212000668 |
News Archive
Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.
Methods currently employed to determine the severity of a heart failure are very limited. Researchers at Eindhoven University of Technology and the Catharina Hospital in Eindhoven have therefore developed a method that is very quick, non-invasive, cost-effective and can be performed at the hospital bedside.
One of the basic tenets of targeted nanoparticle drug delivery is putting multiple targeting molecules on a nanoparticle surface will improve the ability of nanoparticles to stick to their targeted cell and deliver their drug cargos to the appropriate diseased cell.
A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.
› Verified 5 days ago
| Entity Name | Brweye Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609921741 PECOS PAC ID: 6901706993 Enrollment ID: O20040113000786 |
News Archive
Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.
Methods currently employed to determine the severity of a heart failure are very limited. Researchers at Eindhoven University of Technology and the Catharina Hospital in Eindhoven have therefore developed a method that is very quick, non-invasive, cost-effective and can be performed at the hospital bedside.
One of the basic tenets of targeted nanoparticle drug delivery is putting multiple targeting molecules on a nanoparticle surface will improve the ability of nanoparticles to stick to their targeted cell and deliver their drug cargos to the appropriate diseased cell.
A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phillip Carl Hoopes, Jr, MD 11820 S State St, 200, Draper, UT 84020-7160 Ph: (801) 568-0200 | Phillip Carl Hoopes, Jr, MD 11820 S. State St, Ste. 200, Draper, UT 84020-7160 Ph: (801) 568-0200 |
News Archive
Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.
Methods currently employed to determine the severity of a heart failure are very limited. Researchers at Eindhoven University of Technology and the Catharina Hospital in Eindhoven have therefore developed a method that is very quick, non-invasive, cost-effective and can be performed at the hospital bedside.
One of the basic tenets of targeted nanoparticle drug delivery is putting multiple targeting molecules on a nanoparticle surface will improve the ability of nanoparticles to stick to their targeted cell and deliver their drug cargos to the appropriate diseased cell.
A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.
› Verified 5 days ago
Phillip Carl Hoopes Sr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 11820 So State St., 200, Draper, UT 84020 Phone: 801-568-0200 Fax: 801-563-0200 | |
Benjamin Buckner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11820 S State St, Draper, UT 84020 Phone: 573-882-1506 |